MedTrace Logo

Study on Pharmacokinetics

NCT02234882 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-04-17

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of the coadministration of multiple doses of BMS-663068 on the systemic exposure of rosuvastatin.

Conditions

  • HIV Infections

Interventions

DRUG

Rosuvastatin

DRUG

BMS-663068

Sponsors & Collaborators

Principal Investigators

  • ViiV Clinical Trials, MD · ViiV Healthcare

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-05
Primary Completion
2014-10-31
Completion
2014-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02234882 on ClinicalTrials.gov